Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial

PLoS ONE

Volumn 12, Issue 6, 2017, Pages

  Lin, Jessica T ^a   Lon, Chanthap ^b   Spring, Michele D ^c   Sok, Somethy ^d   Chann, Soklyda ^b   Ittiverakul, Mali ^c   Kuntawunginn, Worachet ^c   My, Mok ^b   Thay, Kheangheng ^e   Rahman, Rifat ^a   Balasubramanian, Sujata ^a   Char, Mengchuor ^e   Lanteri, Charlotte A ^c   Gosi, Panita ^c   Ubalee, Ratawan ^c   Meshnick, Steven R ^f   Saunders, David L ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Armed Forces Research Institute of Medical Sciences   (Cambodia)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d Royal Cambodian Armed Forces   (Cambodia)

^e National Center for Parasitology Entomology and Malaria Control   (Cambodia)

^f University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION;

ADULT; AGED; ANOPHELES; ANOPHELES DIRUS; ARTICLE; CAMBODIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ELIMINATION; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; GAMETOCYTE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; NONHUMAN; OOCYST; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; ADOLESCENT; ANIMAL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; DRUG RESISTANCE; MALARIA, FALCIPARUM; PARASITOLOGY; PATHOGENICITY;

ADOLESCENT; ADULT; ANIMALS; ANOPHELES; ANTIMALARIALS; ARTEMISININS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRIMAQUINE;

EID: 85020276557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168702     Document Type: Article

References (44)

1. World Health Organization. Global malaria control and elimination. Report of a meeting on containment of artemisinin tolerance, April 2008. http://www.who.int/malaria/publications/atoz/9789241596817/en/.
2. Maude RJ, Nguon C, Ly P, Bunkea T, Ngor P, Canavati de la Torre SE, et al. Spatial and temporal epidemiology of clinical malaria in Cambodia 2004-2013. Malar J. 2014; 13: 385. doi: 10.1186/1475-2875-13-385
3. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014; 371: 411-423. doi: 10.1056/NEJMoa1314981
4. Saunders DL, Vanachayangkul P, Lon C, U.S. Army Military Malaria Research Program, National Center for Parasitology, Entomology, and Malaria Control (CNM), Royal Cambodian Armed Forces. Dihydroartemisinin-piperaquine failure in Cambodia. N Engl J Med. 2014; 371: 484-485. doi: 10.1056/NEJMc1403007
5. Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: An observational cohort study. Lancet Infect Dis. 2015; 15: 683-691. doi: 10.1016/S1473-3099(15)70049-6
6. Leang R, Taylor WRJ, Bouth DM, Song L, Tarning J, Char MC, et al. Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment. Antimicrob Agents Chemother. 2015; 59: 4719-4726. doi: 10.1128/AAC.00835-15
7. World Health Organization. Guidelines for the Treatment of Malaria, 2010. Geneva: World Health Organization; 2010.
8. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo APP, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: An open-label randomised trial. Lancet Infect Dis. 2010; 10: 673-681. doi: 10.1016/S1473-3099(10)70187-0
9. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, et al. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxinepyrimethamine and artesunate. PloS One. 2007; 2: e1023. doi: 10.1371/journal.pone.0001023
10. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ. Activities of artesunate and primaquine against asexual-And sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother. 2004; 48: 1329-1334. doi: 10.1128/AAC.48.4.1329-1334.2004
11. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, et al. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J. 2010; 9: 136. doi: 10.1186/1475-2875-9-136
12. White NJ. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis. 2013; 13: 175-181. doi: 10.1016/S1473-3099(12)70198-6
13. Chen PQ, Li GQ, Guo XB, He KR, Fu YX, Fu LC, et al. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin Med J (Engl). 1994; 107: 709-711.
14. Dicko A, Brown JM, Diawara H, Baber I, Mahamar A, Soumare HM, et al. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: A single-blind, dose-ranging, adaptive randomised phase 2 trial. Lancet Infect Dis. 2016;
15. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, et al. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: A randomized clinical trial. PloS One. 2011; 6: e19283. doi: 10.1371/journal.pone.0019283
16. Mlambo G, Vasquez Y, LeBlanc R, Sullivan D, Kumar N. A filter paper method for the detection of Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Am J Trop Med Hyg. 2008; 78: 114-116.
17. Lin JT, Bethell D, Tyner SD, Lon C, Shah NK, Saunders DL, et al. Plasmodium falciparum gametocyte carriage is associated with subsequent Plasmodium vivax relapse after treatment. PloS One. 2011; 6: e18716. doi: 10.1371/journal.pone.0018716
18. Lin JT, Ubalee R, Lon C, Balasubramanian S, Kuntawunginn W, Rahman R, et al. Microscopic Plasmodium falciparum Gametocytemia and Infectivity to Mosquitoes in Cambodia. J Infect Dis. 2016; 213: 1491-1494. doi: 10.1093/infdis/jiv599
19. Goncalves BP, Tiono AB, OueÂdraogo A, GuelbeÂogo WM, Bradley J, Nebie I, et al. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemetherlumefantrine in children with asymptomatic infection: A randomised, double-blind, placebo-controlled trial. BMC Med. 2016; 14: 40. doi: 10.1186/s12916-016-0581-y
20. Hii J, Rueda LM. Malaria vectors in the Greater Mekong Subregion: overview of malaria vectors and remaining challenges. Southeast Asian J Trop Med Public Health. 2013; 44 Suppl 1: 73-165; discussion 306-307.
21. World Health Organization. Updated WHO Policy REcommendation (October 2012): Single dose Primaquine as a gametocytocide in Plasmodium falciparum malaria. http://www.who.int/malaria/pq-updated-policy-recommendation-en-102012.pdf. Accessed 20 May 2016.
22. White NJ, Qiao LG, Qi G, Luzzatto L. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J. 2012; 11: 418. doi: 10.1186/1475-2875-11-418
23. Reeve PA, Toaliu H, Kaneko A, Hall JJ, Ganczakowski M. Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency. J Trop Med Hyg. 1992; 95: 349-351.
24. Ashley EA, Recht J, White NJ. Primaquine: The risks and the benefits. Malar J. 2014; 13: 418. doi: 10. 1186/1475-2875-13-418
25. Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S, et al. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother. 2010; 54: 1762-1768. doi: 10.1128/AAC.01135-09
26. Bancone G, Chowwiwat N, Somsakchaicharoen R, Poodpanya L, Moo PK, Gornsawun G, et al. Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects. PloS One. 2016; 11: e0151898. doi: 10.1371/journal.pone.0151898
27. Eziefula AC, Bousema T, Yeung S, Kamya M, Owaraganise A, Gabagaya G, et al. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: A randomised, controlled, double-blind, dose-ranging trial. Lancet Infect Dis. 2014; 14: 130-139. doi: 10.1016/S1473-3099(13)70268-8
28. Stone WJR, Eldering M, van Gemert G-J, Lanke KHW, Grignard L, van de Vegte-Bolmer MG, et al. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays. Sci Rep. 2013; 3: 3418. doi: 10.1038/srep03418
29. Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, et al. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J. 2008; 7: 249. doi: 10. 1186/1475-2875-7-249
30. WWARN Gametocyte Study Group. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: A systematic review and meta-Analysis of individual patient data. BMC Med. 2016; 14: 79. doi: 10.1186/s12916-016-0621-7
31. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, et al. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PloS One. 2009; 4: e4551. doi: 10.1371/journal.pone.0004551
32. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisininresistant malaria on the western border of Thailand: A longitudinal study. Lancet Lond Engl. 2012; 379: 1960-1966.
33. Sutanto I, Suprijanto S, Kosasih A, Dahlan MS, Syafruddin D, Kusriastuti R, et al. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: An open-label, randomized, controlled trial. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013; 56: 685-693.
34. Goncalves BP, Drakeley C, Bousema T. Infectivity of Microscopic and Submicroscopic Malaria Parasite Infections in Areas of Low Malaria Endemicity. J Infect Dis. 2016; 213: 1516-1517. doi: 10.1093/infdis/jiw044
35. Lin JT, Meshnick SR, Saunders DL, Lon C. Reply to Goncalves et al. J Infect Dis. 2016; 213: 1517. doi: 10.1093/infdis/jiw045
36. Lin JT, Saunders DL, Meshnick SR. The role of submicroscopic parasitemia in malaria transmission: what is the evidence? Trends Parasitol. 2014; 30: 183-190. doi: 10.1016/j.pt.2014.02.004
37. Zwang J, Ashley EA, Karema C, D'Alessandro U, Smithuis F, Dorsey G, et al. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: A prospective multi-centre individual patient data analysis. PloS One. 2009; 4: e6358. doi: 10.1371/journal.pone.0006358
38. Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, et al. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: A randomized trial. J Infect Dis. 2013; 207: 1637-1645. doi: 10.1093/infdis/jit077
39. Cambodia Ministry of Health. National Treatment Guidelines for Malaria in Cambodia, December 2014.
40. Saunders D, Lon C. Combination therapies for malaria are failing-what next? Lancet Infect Dis. 2016; 16: 274-275. doi: 10.1016/S1473-3099(15)00525-3
41. White NJ, Ashley EA, Recht J, Delves MJ, Ruecker A, Smithuis FM, et al. Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar J. 2014; 13: 483. doi: 10. 1186/1475-2875-13-483
42. Schneider P, Reece SE, van Schaijk BCL, Bousema T, Lanke KHW, Meaden CSJ, et al. Quantification of female and male Plasmodium falciparum gametocytes by reverse transcriptase quantitative PCR. Mol Biochem Parasitol. 2015; 199: 29-33. doi: 10.1016/j.molbiopara.2015.03.006
43. Mackerras MJ, Ercole QN. Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1949; 42: 455-463.
44. Chen I, Poirot E, Newman M, Kandula D, Shah R, Hwang J, et al. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa. Malar J. 2015; 14: 204. doi: 10.1186/s12936-015-0714-3.